These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16555558)

  • 21. Successful treatment of an equine preputial fibrosarcoma using 5-fluorouracil/evaluation of the treatment using quantitative PCNA and Ki67 (MIB 1) immunostaining. (case report).
    Roels S; Ducatelle R; van De Vijver B; De Kruif A
    Zentralbl Veterinarmed A; 1998 Dec; 45(10):591-8. PubMed ID: 9923141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004).
    Hewes CA; Sullins KE
    J Am Vet Med Assoc; 2006 Nov; 229(10):1617-22. PubMed ID: 17107319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2.
    Spoormakers TJ; Klein WR; Jacobs JJ; Van Den Ingh TS; Koten JW; Den Otter W
    Cancer Immunol Immunother; 2003 Mar; 52(3):179-84. PubMed ID: 12649747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macroscopical and histopathological changes in regressing primary and recurrent equine sarcoids during active specific bio-immunotherapy.
    Hallamaa RE; Saario E; Tallberg T
    In Vivo; 2005; 19(4):761-7. PubMed ID: 15999546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical use of 5% acyclovir cream for the treatment of occult and verrucous equine sarcoids: a double-blinded placebo-controlled study.
    Haspeslagh M; Jordana Garcia M; Vlaminck LEM; Martens AM
    BMC Vet Res; 2017 Oct; 13(1):296. PubMed ID: 28985733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of infiltrating immune cells and bovine papillomavirus type 1 E2-positive cells in equine sarcoids.
    Geisshüsler H; Marti E; Stoffel MH; Kühni K; Stojiljkovic A; von Tscharner C; Vidondo B; Gerber V; Koch C
    Vet J; 2016 Oct; 216():45-52. PubMed ID: 27687925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratumoral chemotherapy with cisplatin in oily emulsion in horses.
    Théon AP; Pascoe JR; Carlson GP; Krag DN
    J Am Vet Med Assoc; 1993 Jan; 202(2):261-7. PubMed ID: 8428832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA).
    Broström H
    Acta Vet Scand; 1995; 36(2):223-36. PubMed ID: 7484549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathomorphological and immunohistochemical study of selected markers of tumour cell proliferation in equine sarcoids.
    Kasperowicz B; Rotkiewicz T; Otrocka-Domagała I
    Pol J Vet Sci; 2006; 9(2):109-19. PubMed ID: 16780178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equine sarcoid tumour treated by autogenous tumour vaccine.
    Kinnunen RE; Tallberg T; Stenbäck H; Sarna S
    Anticancer Res; 1999; 19(4C):3367-74. PubMed ID: 10629622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).
    Rothacker CC; Boyle AG; Levine DG
    Can Vet J; 2015 Jul; 56(7):709-14. PubMed ID: 26130832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental treatment of equine sarcoid using a xanthate compound and recombinant human tumour necrosis factor alpha.
    Otten N; Marti E; Söderström C; Amtmann E; Burger D; Gerber H; Lazary S
    Zentralbl Veterinarmed A; 1994 Dec; 41(10):757-65. PubMed ID: 7653114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycolysis inhibition improves photodynamic therapy response rates for equine sarcoids.
    Golding JP; Kemp-Symonds JG; Dobson JM
    Vet Comp Oncol; 2017 Dec; 15(4):1543-1552. PubMed ID: 28127949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Locally Injected Mycobacterium Cell Wall Fraction in Horses with Sarcoids.
    Caston SS; Sponseller BA; Dembek KA; Hostetter JM
    J Equine Vet Sci; 2020 Jul; 90():103102. PubMed ID: 32534762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of periocular and non-ocular sarcoids in 18 horses by interstitial brachytherapy with iridium-192.
    Byam-Cook KL; Henson FM; Slater JD
    Vet Rec; 2006 Sep; 159(11):337-41. PubMed ID: 16963712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment.
    Wilson AD; Hicks C
    Vet Res; 2016 May; 47(1):55. PubMed ID: 27160146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of equine sarcoids by topical aciclovir application.
    Stadler S; Kainzbauer C; Haralambus R; Brehm W; Hainisch E; Brandt S
    Vet Rec; 2011 Feb; 168(7):187. PubMed ID: 21493530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical distribution of acyclovir in normal equine skin and equine sarcoids: An in vitro study.
    Haspeslagh M; Taevernier L; Maes AA; Vlaminck LE; De Spiegeleer B; Croubels SM; Martens AM
    Res Vet Sci; 2016 Jun; 106():107-11. PubMed ID: 27234546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.
    Martano M; Corteggio A; Restucci B; De Biase ME; Borzacchiello G; Maiolino P
    BMC Vet Res; 2016 Feb; 12():24. PubMed ID: 26838095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses.
    Théon AP; Pascoe JR; Galuppo LD; Fisher PE; Griffey SM; Madigan JE
    J Am Vet Med Assoc; 1999 Dec; 215(11):1655-60. PubMed ID: 14567430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.